Grenoble: the smart move for American Investment. Are they only here for the mountains ?”
MIGAS '13 : International summer school on microelectronic
CEA-Leti Innovation Days
International Conference on Public Policy
1st International Workshop on Nanopackaging
Introductory Course on Magnetic Random Access Memories (InMRAM)
ICBIC 16 - International Conference on Bio Inorganic Chemistry
ESONN'13
ISSW International Snow Science Workshop 2013
Grenoble-Isère enjoys a long-standing reputation as a hub for high-tech industries. Today, Grenoble-Isère is making inroads into the medical technology field. The global medical technology market has grown steadily over the past 50 years, and is dominated by ten leaders - four with operations in Grenoble-Isère: GE Healthcare, Becton Dickinson, Roche Diagnostics, and Covidien. In addition to these majors, Grenoble-Isère is also home to top medtech companies like shoulder prosthetics specialist Tornier, x-ray imaging leader Trixell, and diagnostics solutions provider Biomérieux. Like many other medtech companies, bioMérieux decided to move to Grenoble-Isère to leverage the area’s technology expertise.
Part 1 - Joëlle Seux, Sr. Coordinator, International Investment projects, AEPI
Medtech businesses are now coming to Grenoble to take advantage of technologies originally developed for other industries. We can now say that Grenoble is known throughout the industry as “Medtech Valley.
Part 2 - Bertrand Le Bert, CEO Roche Diagnostics France
Roche Diagnostics France, a Roche subsidiary, specializes in in vitro diagnostics. The company is a leader in the French market and boasts four business lines: biological testing, histopathology, research, and diabetes. The company has been growing steadily and acquired Ventana Medical in 2008, making it the global leader in histopathological testing.
Part 3 - Fluotpics: Philippe Rizzo, CSO & Odile Allard, CEO
Fluoptics is a start-up offering innovative guided surgery systems. The company’s products combine an injectable fluorescent probe that specifically targets tumors with an optical imaging system capable of detecting fluorescence.